C M Booth
Overview
Explore the profile of C M Booth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apte S, Majumdar S, Agborsangaya C, Rueda-Clausen C, Klarenbach S, Sharma A, et al.
Can J Surg
. 2025 Jan;
57(4suppl1):S85-S139.
PMID: 39818541
No abstract available.
2.
Wilson B, Booth C, Patel S, Berry S, Kong W, Merchant S
Clin Oncol (R Coll Radiol)
. 2024 Jan;
36(4):211-220.
PMID: 38199907
Aims: Clinical practice guidelines recommend palliative chemotherapy for most patients with metastatic colorectal cancer. However, outcomes observed in the real world compared with patients enrolled in clinical trials have not...
3.
Castelo-Branco L, Pellat A, Martins-Branco D, Valachis A, Derksen J, Suijkerbuijk K, et al.
Ann Oncol
. 2023 Oct;
34(12):1097-1112.
PMID: 37848160
No abstract available.
4.
Manirakiza A, Rubagumya F, Mushonga M, Mutebi M, Lasebikan N, Kochbati L, et al.
J Cancer Policy
. 2023 Jul;
37:100430.
PMID: 37392842
Background: Cancer incidence and mortality are rapidly rising in Africa. National Cancer Control Plans (NCCPs have contributed to a reduction in the burden of some preventable cancers, availing early diagnosis...
5.
Fundytus A, Wells J, Sharma S, Hopman W, Del Paggio J, Gyawali B, et al.
Clin Oncol (R Coll Radiol)
. 2021 Sep;
34(1):28-35.
PMID: 34479769
Aims: Most randomised controlled trials (RCTs) in oncology are now funded by the pharmaceutical industry. We explore the extent to which RCT design, results and interpretation differ between industry-funded and...
6.
Fundytus A, Booth C, Tannock I
Ann Oncol
. 2021 Apr;
32(7):833-836.
PMID: 33839260
No abstract available.
7.
Raphael M, Lougheed M, Wei X, Karim S, Robinson A, Bedard P, et al.
Curr Oncol
. 2020 Dec;
27(6):291-298.
PMID: 33380860
Background: Bleomycin is commonly used to treat advanced testicular cancer and can be associated with severe pulmonary toxicity. The primary objective of the present study was to describe the use...
8.
Merchant S, Kong W, Gyawali B, Hanna T, Chung W, Nanji S, et al.
Clin Oncol (R Coll Radiol)
. 2020 Aug;
33(3):202-207.
PMID: 32747152
Aims: In the pivotal Trastuzumab for Gastric Cancer (ToGA) trial, trastuzumab improved median survival in patients with advanced HER-2-positive gastric and gastroesophageal cancer from 11.1 to 13.8 months; however, its...
9.
Robinson A, Wei X, Karim S, Raphael M, Bedard P, Booth C
Clin Oncol (R Coll Radiol)
. 2020 May;
32(10):e188-e193.
PMID: 32387044
Aims: Venous thromboembolism (VTE) is a potential complication among germ cell tumour patients. We evaluated the incidence rate, timing and factors associated with VTE among patients with germ cell cancer...
10.
Seruga B, Sullivan R, Fundytus A, Hopman W, Ocana A, Joffe J, et al.
Clin Oncol (R Coll Radiol)
. 2019 Jul;
32(1):e19-e26.
PMID: 31324474
Aims: The workload pressure on medical oncologists will increase in the near future. There are no comprehensive data available about the current workload of medical oncologists in Europe. Here we...